210 related articles for article (PubMed ID: 7694581)
1. Expression and mutational analysis of the reverse transcriptase of the lentivirus equine infectious anemia virus.
Shaharabany M; Rice NR; Hizi A
Biochem Biophys Res Commun; 1993 Oct; 196(2):914-20. PubMed ID: 7694581
[TBL] [Abstract][Full Text] [Related]
2. [Polymerase and immunologic activity of reverse transcriptase of the HIV-1 virus, isolated from Escherichia coli].
Shvetsov IuP; Mel'nikov AA; Suvorova ZK; Kopylova-Sviridova TN; Pokrovskiĭ VV; Fodor II
Mol Gen Mikrobiol Virusol; 1991 Mar; (3):22-4. PubMed ID: 1713297
[TBL] [Abstract][Full Text] [Related]
3. The catalytic properties of the reverse transcriptase of the lentivirus equine infectious anemia virus.
Rubinek T; Loya S; Shaharabany M; Hughes SH; Clark PK; Hizi A
Eur J Biochem; 1994 Feb; 219(3):977-83. PubMed ID: 7509281
[TBL] [Abstract][Full Text] [Related]
4. Involvement of C-terminal structural elements of equine infectious anemia virus reverse transcriptase in DNA polymerase and ribonuclease H activities.
Rausch JW; Arts EJ; Wöhrl BM; Le Grice SF
J Mol Biol; 1996 Apr; 257(3):500-11. PubMed ID: 8648620
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the polymerization kinetics of homodimeric EIAV p51/51 reverse transcriptase implies the formation of a polymerase active site identical to heterodimeric EIAV p66/51 reverse transcriptase.
Souquet M; Restle T; Krebs R; Le Grice SF; Goody RS; Wöhrl BM
Biochemistry; 1998 Sep; 37(35):12144-52. PubMed ID: 9724526
[TBL] [Abstract][Full Text] [Related]
6. Purification and partial characterization of equine infectious anemia virus reverse transcriptase.
DeVico A; Montelaro RC; Gallo RC; Sarngadharan MG
Virology; 1991 Nov; 185(1):387-94. PubMed ID: 1718086
[TBL] [Abstract][Full Text] [Related]
7. [Reverse transcriptase of the human immunodeficiency virus: cloning, expression in Escherichia coli, purification of the enzyme, and production of monoclonal antibodies].
Rechinskiĭ VO; Barbashov SF; Degtiarev IL; Vorob'ev SM; Liakhov DL; Kostiuk DA; Starov AI; Matsevich GR; Kochetkov SN
Mol Biol (Mosk); 1991; 25(5):1248-57. PubMed ID: 1721676
[TBL] [Abstract][Full Text] [Related]
8. Analysis of interactions of DNA polymerase beta and reverse transcriptases of human immunodeficiency and mouse leukemia viruses with dNTP analogs containing a modified sugar residue.
Lebedeva NA; Seredina TA; Silnikov VN; Abramova TV; Levina AS; Khodyreva SN; Rechkunova NI; Lavrik OI
Biochemistry (Mosc); 2005 Jan; 70(1):1-7. PubMed ID: 15701045
[TBL] [Abstract][Full Text] [Related]
9. In vitro enzymatic activity of human immunodeficiency virus type 1 reverse transcriptase mutants in the highly conserved YMDD amino acid motif correlates with the infectious potential of the proviral genome.
Wakefield JK; Jablonski SA; Morrow CD
J Virol; 1992 Nov; 66(11):6806-12. PubMed ID: 1383571
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of recombinant equine infectious anemia virus reverse transcriptase.
Le Grice SF; Panin M; Kalayjian RC; Richter NJ; Keith G; Darlix JL; Payne SL
J Virol; 1991 Dec; 65(12):7004-7. PubMed ID: 1719238
[TBL] [Abstract][Full Text] [Related]
11. Expression of polypeptides of human immunodeficiency virus-1 reverse transcriptase in Escherichia coli.
Becerra SP; Kumar A; Wilson SH
Protein Expr Purif; 1993 Jun; 4(3):187-99. PubMed ID: 7686063
[TBL] [Abstract][Full Text] [Related]
12. Fidelity of DNA synthesis exhibited in vitro by the reverse transcriptase of the lentivirus equine infectious anemia virus.
Bakhanashvili M; Hizi A
Biochemistry; 1993 Jul; 32(29):7559-67. PubMed ID: 7687876
[TBL] [Abstract][Full Text] [Related]
13. [Reverse transcriptase of the human immunodeficiency virus: isolation and substrate specificity].
Rozovskaia TA; Belogurov AA; Lukin MA; Chernov DN; Kukhanova MK; Bibilashvili RSh
Mol Biol (Mosk); 1993; 27(3):618-30. PubMed ID: 7686251
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of the DNA polymerase and ribonuclease H activities of human immunodeficiency virus type 2 reverse transcriptase expressed in Escherichia coli.
Hizi A; Tal R; Hughes SH
Virology; 1991 Jan; 180(1):339-46. PubMed ID: 1701948
[TBL] [Abstract][Full Text] [Related]
15. Peyssonols A and B, two novel inhibitors of the reverse transcriptases of human immunodeficiency virus types 1 and 2.
Loya S; Bakhanashvili M; Kashman Y; Hizi A
Arch Biochem Biophys; 1995 Feb; 316(2):789-96. PubMed ID: 7532386
[TBL] [Abstract][Full Text] [Related]
16. A replication competent lentivirus (RCL) assay for equine infectious anaemia virus (EIAV)-based lentiviral vectors.
Miskin J; Chipchase D; Rohll J; Beard G; Wardell T; Angell D; Roehl H; Jolly D; Kingsman S; Mitrophanous K
Gene Ther; 2006 Feb; 13(3):196-205. PubMed ID: 16208418
[TBL] [Abstract][Full Text] [Related]
17. Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138.
Pelemans H; Aertsen A; Van Laethem K; Vandamme AM; De Clercq E; Pérez-Pérez MJ; San-Félix A; Velázquez S; Camarasa MJ; Balzarini J
Virology; 2001 Feb; 280(1):97-106. PubMed ID: 11162823
[TBL] [Abstract][Full Text] [Related]
18. Mutagenesis of EIAV TAT reveals structural features essential for transcriptional activation and TAR element recognition.
Derse D; Newbold SH
Virology; 1993 Jun; 194(2):530-6. PubMed ID: 8389074
[TBL] [Abstract][Full Text] [Related]
19. A drug resistance mutation in the inhibitor binding pocket of human immunodeficiency virus type 1 reverse transcriptase impairs DNA synthesis and RNA degradation.
Fan N; Rank KB; Slade DE; Poppe SM; Evans DB; Kopta LA; Olmsted RA; Thomas RC; Tarpley WG; Sharma SK
Biochemistry; 1996 Jul; 35(30):9737-45. PubMed ID: 8703945
[TBL] [Abstract][Full Text] [Related]
20. Cellular and viral specificity of equine infectious anemia virus Tat transactivation.
Maury WJ; Carpenter S; Graves K; Chesebro B
Virology; 1994 May; 200(2):632-42. PubMed ID: 8178449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
